Doctor profile · Federal record

Dr. Kara Hommerding, PA-C

Physician Assistant · Medical Physician Assistant · Colorado Springs, CO

  • NPI 1760600159
  • Accepts Medicare
  • MIPS 92.7 / 100 · 2023
  • 22 yrs in practice
  • Licensed in 2 states
  • Female
  • Group practice
  • No sanctions

Practice & contact

Operates at 3 locations .

NPPES Updated May 11, 2026
Primary practice
1220 Lake Plaza Dr Ste A
Colorado Springs, CO 809063555
(719) 531-5400
Additional location
1650 Cochrane Cir
Fort Carson, CO 809134613
(719) 526-7160
Additional location
95 Crystal Run RD
Middletown, NY 10941
(845) 703-6999
fax (845) 703-6297

Credentials & registration

NPPES · NUCC
NPI registered
April 2007 — 19 yrs on file
Profile last updated
May 22, 2025
Year of graduation
2004 — 22 yrs since
Specialty taxonomy
363A00000X — NUCC code
State licenses (2)
Colorado #0003974 · New York #022993

Federal sanctions & exclusions

OIG LEIE Updated May 11, 2026

No sanctions, exclusions or revocations on file

Checked against OIG LEIE on NPI 1760600159. Last verified May 11, 2026.

Medicare procedures · 2023

Top services delivered

CMS Provider Utilization
Total services
1,984
Distinct HCPCS
10
Medicare allowed
$102,891
HCPCS Description Services Patients Avg allowed
17003 Destruction of precancer skin growth, 2-14 growths 720 127 $6
99213 Established patient office or other outpatient visit, 20-29 minutes 403 265 $78
17000 Destruction of precancer skin growth, 1 growth 260 178 $46
17110 Destruction of skin growth, 1-14 growths 162 121 $97
99214 Established patient office or other outpatient visit, 30-39 minutes 126 85 $111
11102 Biopsy of related skin growth, first growth 96 80 $76
99203 New patient office or other outpatient visit, 30-44 minutes 76 76 $97
99212 Established patient office or other outpatient visit, 10-19 minutes 54 51 $49
11103 Biopsy of related skin growth, each additional growth 22 16 $45
99202 New patient office or other outpatient visit, 15-29 minutes 18 18 $63

In context: peer comparison

Among 113 peers in this city , average services per provider: 104. This provider delivers 19× the peer median.

Open Payments

Industry payments received

CMS Open Payments
All-time total
$898
Transactions
38
Manufacturers
12
Payer (manufacturer) Industry Txns Amount
GENZYME CORPORATION 7 $222.53
ABBVIE INC. 9 $205.38
Regeneron Healthcare Solutions, Inc. 3 $95.53
Novartis Pharmaceuticals Corporation 4 $87.94
Janssen Biotech, Inc. 4 $81.25
Incyte Corporation 3 $47.82
Arcutis Biotherapeutics, Inc. 2 $42.02
UCB, Inc. 2 $39.21
Lilly USA, LLC 1 $20.91
Ortho Dermatologics, a division of Bausch Health US, LLC 1 $19.89
SUN PHARMACEUTICAL INDUSTRIES INC. 1 $19.77
PFIZER INC. 1 $15.44

By nature of payment

Food and Beverage
$898

Medicare Part D · 2023

Top prescriptions

CMS Part D Prescriber
Total claims
239
Patients
140
Total drug cost
$15,793
Drug Type Claims Patients Total cost
Ketoconazole Generic 81 47 $2,959
Triamcinolone Acetonide Generic 41 32 $279
Clobetasol Propionate Generic 28 21 $2,771
Doxycycline Hyclate Generic 28 15 $1,321
Clindamycin Phosphate Generic 19 0 $585
Ammonium Lactate Generic 14 12 $292
Mupirocin Generic 14 13 $150
Tacrolimus Generic 14 0 $7,437

Frequently asked questions

Auto-generated from federal data
What is Dr. Kara Hommerding's medical specialty?
Dr. Kara Hommerding practices Physician Assistant in Colorado Springs, CO.
Where does Dr. Kara Hommerding practice?
Dr. Kara Hommerding practices at 1220 Lake Plaza Dr Ste A, Colorado Springs, CO 809063555. Office phone: 7195315400.
What is Dr. Kara Hommerding's NPI?
Dr. Kara Hommerding's National Provider Identifier (NPI) is 1760600159, issued by NPPES.
Does Dr. Kara Hommerding accept Medicare assignment?
Yes. Dr. Kara Hommerding accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Kara Hommerding commonly perform?
Top Medicare-reported procedures in 2023: Destruction of precancer skin growth, 2-14 growths (HCPCS 17003); Established patient office or other outpatient visit (HCPCS 99213); Destruction of precancer skin growth, 1 growth (HCPCS 17000). Source: CMS Medicare Physician & Other Practitioners file.